Articoli correlati a Breakthrough Business Models: Drug Development for...

Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Drug Development for Rare and Neglected ... Individualized Therapies: Workshop Summary - Brossura

Wizemann, Theresa M.; Robinson, Sally; Giffin, Robert; Institute Of Medicine (U. S.)

 
9780309120883: Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Drug Development for Rare and Neglected ... Individualized Therapies: Workshop Summary
Brossura
ISBN 10: 0309120888 ISBN 13: 9780309120883
Casa editrice: Natl Academy Pr, 2009

Sinossi

The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and neglected diseases are unable to rely on such returns. On June 23, 2008, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies," which sought to explore new and innovative strategies for developing drugs for rare and neglected diseases.

Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.

Editore
Natl Academy Pr
Data di pubblicazione
2009
Lingua
Inglese
ISBN 10 
0309120888
ISBN 13 
9780309120883
Rilegatura
Copertina flessibile
Numero di pagine
131
Contatto del produttore
non disponibile
Persona responsabile
non disponibile